Showing results (1931-1940 of 2,072) with videos related to
Sort By:
Pageof 208
Plos One|November 21, 2017
Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritisYi-Ming Chen, Hsin-Hua Chen, Wen-Nan Huang, et al.British Journal of Haematology|March 11, 2025
Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopeniaTian-Shu Yu, Shou-Qing Han, Ling-Jun Wang, et al.The American Journal of Medicine|June 30, 2026
GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort StudySsu-Yu Pan, Chien-Hsiang Weng, Yi-Jing Sheen, et al.Disease Markers|June 12, 2015
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell CarcinomaHang Yang, Wen-Qi Jiang, Ye Cao, et al.Molecular and Cellular Biochemistry|February 23, 2016
PI3K/Akt/FoxO3a signaling mediates cardioprotection of FGF-2 against hydrogen peroxide-induced apoptosis in H9c2 cellsMi-Hua Liu, Guo-Hua Li, Li-Jun Peng, et al.Cellular and Molecular Life Sciences : CMLS|April 19, 2022
Platelets fine-tune effector responses of naïve CD4+ T cells via platelet factor 4-regulated transforming growth factor β signalingYanan Min, Long Hao, Xinguang Liu, et al.Diagnostic Pathology|September 7, 2024
Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic reviewYou-Yuan Su, Ya-Fei Yu, Zhen-Yu Yan, et al.Frontiers in Oncology|August 9, 2021
Targeting NUFIP1 Suppresses Growth and Induces Senescence of Colorectal Cancer CellsAling Shen, Meizhu Wu, Liya Liu, et al.Oncotarget|September 18, 2015
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancerTao Qin, Yin-duo Zeng, Ge Qin, et al.Annals of Surgical Oncology|July 5, 2018
Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?Jian-Xian Lin, Wei Wang, Jun-Peng Lin, et al.Pageof 208